Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?
This trial is active, not recruiting.
|Sponsor||Sheba Medical Center|
|Start date||March 2014|
|End date||April 2016|
|Trial size||200 participants|
|Trial identifier||NCT02083939, SHEBA-12-9550-DR-CTIL|
The purpose of this study is to find out whether it is necessary to prophylactically treat patients undergoing laparoscopic inguinal hernia repairs with antibiotics. Our hypothesis is that it is not necessary to pretreat patients with antibiotics if the operation is minimally invasive with a mesh placed at the defect.
This cohort will receive antibiotic prophylaxis prior to the hernia repair
This cohort will not receive antibiotic prophylaxis prior to the surgery
Incidence of surgical site infection
time frame: One year post-operation
Male or female participants at least 18 years old.
Inclusion Criteria: - Elective laparoscopic inguinal hernia repair, unilateral or bilateral Exclusion Criteria: - Those requiring antibiotics for the surgery; - Those patients who have experienced surgical site infections from previous surgeries
|Official title||Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?|
|Principal investigator||Danny Rosin, MD|
|Description||The investigators plan to follow up at least 100 patients who did not receive antibiotics prior to their inguinal hernia repair and compare their outcome to 100 patients who did receive prophylaxis. The investigators mainly will be analyzing the incidence of surgical site infections as evidenced by swelling, redness, pain, warmth or other signs deemed by the surgeon.|
Call for more information